![]() |
市場調查報告書
商品編碼
1734816
2032 年內視鏡封閉系統市場預測:按產品類型、應用、最終用戶和地區進行的全球分析Endoscopic Closure Systems Market Forecasts to 2032 - Global Analysis By Product Type (Clips, Endoscopic Suturing Systems, Endoscopic Banding Devices and Other Product Types), Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球內視鏡閉合系統市場預計在 2025 年達到 6.117 億美元,到 2032 年達到 10.483 億美元,預測期內的複合年成長率為 8%。
內視鏡閉合系統是一種在微創手術過程中用於閉合內部組織切口或開口的醫療設備。這些系統通常由縫線、釘書釘和夾子組成,透過內視鏡傳送以實現閉合,而無需進行大切口。與傳統的開放性手術相比,它通常用於胃腸道、減肥和外科手術,以促進癒合、減少併發症並縮短患者的康復時間。
根據美國胃腸內視鏡學會 (ASGE) 的數據,光是在美國,每年就進行約 2,000 萬例內視鏡檢查。
胃腸道疾病增多
胃腸道(GI)疾病盛行率的不斷上升是內視鏡封閉系統市場發展的主要驅動力。隨著全球大腸直腸癌、發炎性腸道疾病疾病和消化性潰瘍等疾病負擔的增加,對侵入性更小、恢復更快的先進外科手術干預的需求日益成長。內視鏡閉合系統在封閉內部傷口和預防併發症、改善患者預後和縮短住院時間方面發揮關鍵作用。隨著對微創解決方案的需求增加,預計這一趨勢將在未來持續下去,從而進一步推動市場成長。
熟練內視鏡醫師短缺
整合如此先進的設備需要專門的培訓和專業知識,而並非所有醫療保健機構都具備這些培訓和專業知識,尤其是在新興國家。此外,培訓計劃的高成本和複雜性可能會阻礙醫療保健提供者採用這些技術。因此,缺乏經過充分培訓的專業人員限制了內視鏡閉合系統的廣泛應用,阻礙了市場擴張並限制了患者獲得這些先進療法的機會。
全球老年人口不斷成長
老年人更容易患慢性疾病,包括胃腸道疾病,並且通常需要手術干預。由於恢復時間更快、併發症風險更低,老年族群更傾向於微創手術,這推動了對內視鏡閉合系統的需求。這種人口結構變化,加上醫療基礎設施的進步和醫療支出的增加,預計將顯著推動已開發市場和新興市場的市場成長。
手術相關併發症的風險
儘管內視鏡閉合手術有其優點,但它也存在固有的風險,包括感染、設備移位和術後併發症。這些風險可能會危及病人安全並導致額外的干涉,增加醫療成本並阻礙此類系統的採用。此外,對一次性設備醫療廢棄物的擔憂以及對更強大、更可靠的封閉解決方案的需求進一步使市場動態複雜化。
由於選擇性手術延遲和醫院就診人數減少,COVID-19 疫情最初擾亂了內視鏡閉合系統市場。隨著醫療資源轉向對抗疫情,內視鏡手術暫時減少。然而,隨著限制的放寬和醫療保健系統的適應,對微創手術的需求已經恢復。疫情也加速了遠端醫療和遠端監控的採用,透過促進患者管理和內視鏡手術的後續治療,間接地支持了市場。
止血(出血控制)領域預計將成為預測期內最大的市場
預計在預測期內,止血(控制出血)部分將佔據最大的市場佔有率。這項優點源自於內視鏡檢查過程中對有效控制出血的迫切需求,特別是在涉及消化性潰瘍、靜脈曲張出血和息肉切除術後介入的情況下。內視鏡止血夾等止血裝置可立即可靠地控制出血,降低併發症的風險並減少採用更具侵入性的手術方法的需要。全球範圍內胃腸道疾病的發病率不斷上升以及內視鏡手術的增加進一步鞏固了該主導市場地位。
預計預測期內門診手術中心 (ASC) 部分將以最高的複合年成長率成長。
預計門診手術中心 (ASC) 部門將在預測期內見證最高的成長率。這種快速擴張的原因是人們對門診病人和具有成本效益的手術程序的偏好日益成長,因為與傳統醫院環境相比,ASC 可以縮短住院時間、降低感染風險並降低醫療成本。 ASC 採用微創技術,加上內視鏡閉合技術的進步,使得這些中心成為患者和醫療保健提供者的首選。
預計北美地區將在預測期內佔據最大的市場佔有率。這項優勢由多種因素推動,包括高昂的醫療費用、早期採用先進的醫療技術以及完善的醫療保健基礎設施。此外,該地區擁有大量經驗豐富的內視鏡醫師和主要市場參與企業,可以快速採用創新的封閉系統。此外,優惠的報銷政策和胃腸道疾病的高盛行率也促成了該地區較大的市場佔有率。
預計亞太地區在預測期內的複合年成長率最高。這一顯著成長可歸因於醫療保健投資的增加、人們對微創手術的認知的提高以及老年人口的增加。此外,胃腸道疾病的快速成長和政府為提高醫療保健可及性而採取的舉措正在加速中國和印度等國家採用先進的內視鏡技術。該地區醫療保健基礎設施的擴大和具有成本效益的解決方案的進入預計將進一步推動強勁的市場成長。
According to Stratistics MRC, the Global Endoscopic Closure Systems Market is accounted for $611.7 million in 2025 and is expected to reach $1048.3 million by 2032 growing at a CAGR of 8% during the forecast period. Endoscopic closure systems are medical devices used to close incisions or openings in internal tissues during minimally invasive procedures. These systems typically consist of sutures, staples, or clips delivered through an endoscope to achieve closure without the need for large incisions. They are commonly used in gastrointestinal, bariatric, and surgical applications to promote healing, reduce complications, and improve patient recovery time compared to traditional open surgery methods.
According to the American Society for Gastrointestinal Endoscopy (ASGE), approximately 20 million endoscopic procedures are performed annually in the United States alone.
Rising incidence of gastrointestinal (GI) disorders
The growing prevalence of gastrointestinal (GI) disorders is a significant driver for the endoscopic closure systems market. As the global burden of conditions such as colorectal cancer, inflammatory bowel disease, and peptic ulcers rises, there is an increasing need for advanced surgical interventions that are less invasive and offer faster recovery. Endoscopic closure systems play a crucial role in sealing internal wounds and preventing complications during these procedures, which enhances patient outcomes and reduces hospital stays. This trend is expected to continue, further fueling market growth as the demand for minimally invasive solutions escalates.
Limited skilled endoscopists
The integration of these sophisticated devices requires specialized training and expertise, which are not uniformly available across all healthcare settings, particularly in emerging economies. Additionally, the high cost and complexity of training programs can deter healthcare providers from adopting these technologies. As a result, the lack of adequately trained professionals restricts the broader adoption of endoscopic closure systems, thereby impeding market expansion and limiting patient access to these advanced treatments.
Rising geriatric population globally
Older adults are more susceptible to chronic diseases, including GI disorders, which often require surgical intervention. The preference for minimally invasive procedures among elderly patients-due to reduced recovery times and lower complication risks-drives demand for endoscopic closure systems. This demographic shift, coupled with advancements in healthcare infrastructure and increased healthcare spending, is expected to significantly boost market growth in both developed and developing regions.
Risk of procedure-related complications
Despite their benefits, endoscopic closure procedures carry inherent risks, such as infection, device migration, and post-procedural complications. These risks can undermine patient safety and lead to additional interventions, increasing healthcare costs and potentially deterring the adoption of such systems. Moreover, concerns over medical waste from disposable devices and the need for more robust, reliable closure solutions further complicate market dynamics.
The Covid-19 pandemic initially disrupted the endoscopic closure systems market due to the postponement of elective surgeries and reduced hospital visits. Healthcare resources were redirected to manage the pandemic, leading to a temporary decline in endoscopic procedures. However, as restrictions eased and healthcare systems adapted, there was a resurgence in demand for minimally invasive treatments. The pandemic also accelerated the adoption of telemedicine and remote monitoring, which indirectly supported the market by facilitating patient management and follow-up care for endoscopic interventions.
The hemostasis (Management of Bleeding) segment is expected to be the largest during the forecast period
The hemostasis (Management of Bleeding) segment is expected to account for the largest market share during the forecast period. This dominance is attributed to the critical need for effective bleeding control during endoscopic procedures, particularly in cases involving peptic ulcers, variceal bleeding, and post-polypectomy interventions. Hemostasis devices, such as endoscopic hemoclips, provide immediate and reliable control of bleeding, reducing the risk of complications and the need for more invasive surgical approaches. The increasing prevalence of GI disorders and the growing number of endoscopic procedures globally further reinforce the segment's leading position in the market.
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate. This rapid expansion is driven by the increasing preference for outpatient and cost-effective surgical procedures, as ASCs offer shorter hospital stays, lower infection risks, and reduced healthcare costs compared to traditional hospital settings. The adoption of minimally invasive techniques in ASCs, coupled with advancements in endoscopic closure technologies, is making these centers a preferred choice for both patients and healthcare providers.
During the forecast period, the North America region is expected to hold the largest market share. This dominance is underpinned by several factors, including high healthcare expenditure, early adoption of advanced medical technologies, and a well-established healthcare infrastructure. The region also benefits from a large base of skilled endoscopists and a strong presence of major market players, which facilitates the rapid uptake of innovative closure systems. Additionally, favorable reimbursement policies and a high prevalence of GI disorders contribute to the region's substantial market share.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is fueled by rising healthcare investments, increasing awareness of minimally invasive procedures, and a growing geriatric population. Furthermore, the surge in GI disorders and government initiatives to enhance healthcare access are accelerating the adoption of advanced endoscopic technologies across countries like China and India. The region's expanding healthcare infrastructure and the entry of cost-effective solutions are expected to further drive robust market growth.
Key players in the market
Some of the key players in Endoscopic Closure Systems Market include CooperSurgical Inc., Abbott Laboratories, Apollo Endosurgery Inc., Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, Duomed Group, ENDO-FLEX GmbH, EnVision Endoscopy, Johnson & Johnson Services Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., Micro-Tech USA Incorporated, Olympus Corporation, Ovesco Endoscopy AG, Steris plc, US Endoscopy and B. Braun Melsungen AG.
In April 2025, Abbott Laboratories showcased the Perclose(TM) ProStyle(TM) Suture-Mediated Closure and Repair System at HRS 2025.
In April 2025, Medtronic plc announced a distribution agreement with Dragonfly(TM) Endoscopy for pancreaticobiliary endoscopic closure solutions.
In April 2025, Boston Scientific Corporation introduced the MANTIS(TM) Clip and X-Tack(TM) Endoscopic HeliX Tacking System.